Status:
UNKNOWN
The Incidence of TRALI in Patients Undergoing Orthopedic-Oncology Surgery
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Dyspnea
Pulmonary Edema
Eligibility:
All Genders
18-90 years
Brief Summary
Currently Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality in the United States, and one of major post-transfusion complications. TRALI is defined as...
Detailed Description
Background The transfusion of blood products is occasionally complicated by acute lung injury (ALI), which can progress to the acute respiratory distress syndrome (ARDS). Such transfusion-related acu...
Eligibility Criteria
Inclusion
- Patients aged \>18 years old, with ASA I-III, undergoing elective orthopedic-oncology procedures in the Sourasky Medical Center, and receiving blood products pre-, intra-, or post-operatively.
Exclusion
- Patients with a history of chronic renal insufficiency (creatinine \> 1.5 of normal value), congestive heart failure, hepatic dysfunction, preexisting ALI, or acute infection.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00914784
Start Date
August 1 2009
End Date
September 1 2011
Last Update
June 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky medical center
Tel Aviv, Israel, 64239